Back to all papers

Artificial Intelligence in Lung Diseases: Screening, Diagnosis, Treatment, and Prognosis.

November 18, 2026pubmed logopapers

Authors

Chen F,Yang J,Zhang Y,Chen K,Fang Z,Chen H,Wang Z

Affiliations (6)

  • Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Shanghai Pudong Hospital, Fudan University, Shanghai, China.
  • Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Department of Oncology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Colorectal Surgery and Oncology of the Second Affiliated Hospital, and Centre of Biomedical Systems and Informatics of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Shanghai Cancer Center, Fudan University, Shanghai, China. [email protected].
  • Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Shanghai Pudong Hospital, Fudan University, Shanghai, China. [email protected].

Abstract

Pulmonary diseases currently pose significant threats to global health, spanning common chronic conditions including lung cancer, chronic obstructive pulmonary disease (COPD), and asthma, as well as infectious and inflammatory diseases like tuberculosis, interstitial lung disease (ILD), and COVID-19. Therefore, accurate diagnosis, effective therapeutic strategies, and reliable assessment of prognosis for pulmonary diseases are essential for improving patient outcomes and safeguarding public health. Despite the increasing availability of medical imaging and pathological data owing to improvements in detection technologies, what is becoming increasingly evident are the limitations of conventional diagnosis, which relies solely on clinicians' subjective judgment based on imaging, pulmonary function, pathology, and clinical experience. In recent years, artificial intelligence (AI) technology, especially machine learning (ML) and deep learning (DL), has made significant progress in areas such as image recognition and model construction. Numerous studies have demonstrated the widespread application of AI in the screening and diagnosis of lung diseases, the optimization of treatment strategies, and prognosis assessment, revealing its remarkable ability to process and interpret complex clinical data. Although concerns persist regarding data quality, the "black box" nature of algorithms, clinical practice, and the regulatory landscape, the application of AI in lung disease research and clinical care is more and more promising. In this review, we summarize the latest advances of AI in the diagnosis and treatment of pulmonary diseases, analyze the challenges and limitations of current AI technologies ranging from data and algorithms to clinical translation, and highlight directions for future research.

Topics

Artificial IntelligenceLung DiseasesJournal ArticleReview

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.